AMMB reported a 4QFY20 net profit of RM247.5m (-35.2% qoq; -1% yoy), while FY20 saw a net profit of RM1,340.7m (-10.9% yoy). Excluding one-offs, i.e. a debt sale gain of RM285m in FY19 and the impact of a RM167.3m macro provision in FY20, underlying net profit grew by 15% yoy. Results were within Affin’s and consensus estimates. 4QFY20 was a dampener to the overall FY20 results, largely due to a pre-emptive macro provision. Nonetheless, we upgrade AMMB from Sell to HOLD on valuation (as the downside has narrowed), with an unchanged 12-month Price Target of RM3.00. We expect a recovery in FY22, though FY21 will likely continue to see heightened provisions, which we believe have been priced in.
For FY20, AMMB’s operating results have been quite steady, with overall fund-based income up 10.5% yoy and non-interest income up 7.5% yoy. Operating expenses were relatively stable yoy (with CIR at 50% vs. 54.3% in FY19). FY20 pre-tax profit declined 15% yoy, however, as management has provided additional macro overlays of RM167m in the provisions for 4QFY20. FY20’s net credit cost (NCC) was 30bps vs. a 30bps credit recovery in FY19 (which includes a debt sale gain). We have factored in a NCC of 39bps for FY21E and 32bps for FY22E.
Though AMMB saw better-than-industry loan growth at 5% yoy, and a NIM improvement of 5bps yoy to 1.94% in FY20, we expect a moderation in FY21E’s operating income, as we expect contraction in overall loan growth at circa 2% due to weak economic circumstances and cautious demand. Meanwhile, as a result of the 50bps OPR cut in May, we expect the FY21E NIM to narrow further to 1.8%.
We upgrade AMMB from Sell to HOLD on valuation with a PT of RM3.00 (based on a 0.46x P/BV on CY21E BVPS). The Day-1 modification loss impact, which will be recognised in the next quarter, is estimated to have a net impact of RM20m, but the subsequent unwinding impact will result in a minimal impact to the bottomline by year-end. AMMB has announced a 7.3 sen final DPS, for a total of 13.3 sen in FY20 vs. 20 sen in FY19 (scaling down payout ratio to 30% from 45-50%). Downside/upside risks: interest rate cuts/hikes; higher/lower impaired loan provisions
Source: Affin Hwang Research - 30 Jun 2020
Chart | Stock Name | Last | Change | Volume |
---|
Created by kltrader | Jan 03, 2023
Created by kltrader | Sep 30, 2022